Acadia Pharmaceuticals Inc (ACAD)
Cost of Revenue
$100.98M
TTM · Period ending: · USD
ACAD Cost of Revenue
Latest reported$100.98Mperiod ending
Latest reported$100.98Mperiod ending
ACAD TTM Cost of Revenue ($0.00 → $100.98M)
TTM cost of revenue
High-resolution chart · PNG
ACAD cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 100,979,000 | |
| 93,397,000 | |
| 88,998,000 | |
| 84,576,000 | |
| 81,786,000 | |
| 79,282,000 | |
| 81,841,000 | |
| 77,929,000 | |
| 73,694,000 | |
| 62,923,000 | |
| 41,639,000 | |
| 26,161,000 | |
| 13,675,000 | |
| 8,883,000 | |
| 10,166,000 | |
| 10,314,000 | |
| 14,860,000 | |
| 17,399,000 | |
| 19,141,000 | |
| 21,881,000 | |
| 20,000,000 | |
| 20,268,000 | |
| 20,550,000 | |
| 20,583,000 | |
| 20,471,000 | |
| 19,992,000 | |
| 19,598,000 | |
| 18,656,000 | |
| 19,342,000 | |
| 19,425,000 | |
| 18,330,000 | |
| 17,641,000 | |
| 15,479,000 | |
| 13,607,000 | |
| 13,060,000 | |
| 11,669,000 | |
| 9,776,000 | |
| 7,344,000 | |
| 27,181,000 | |
| 47,835,000 | |
| 65,244,000 | |
| 82,849,000 | |
| 76,369,000 | |
| 71,585,000 | |
| 69,808,000 | |
| 65,228,000 | |
| 60,601,000 | |
| 50,344,000 | |
| 40,646,000 | |
| 33,959,000 | |
| 26,721,000 | |
| 23,697,000 | |
| 20,843,000 | |
| 13,731,000 | |
| 9,301,000 | |
| 4,400,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |